Guangwen Cao

16.2k citations
425 papers · 10.1k indexed · 1 hit paper · h-index 52
Topics
Hepatitis B Virus Studies (55 papers)Liver Disease Diagnosis and Treatment (38 papers)Hepatitis C virus research (36 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Guangwen Cao

396 papers receiving 9.8k citations

Hit Papers

A pyroptosis nanotuner for cancer therapy2022202620232024202250100150200

Peers

Guangwen Cao
Comparison fields: 5 of 205
  • Molecular Biology 3.1k
  • Epidemiology 2.2k
  • Hepatology 1.8k
  • Cancer Research 1.3k
  • Oncology 1.3k
Replace ­Jun Li­ with:
­Jun Li­ China
Li Liu China
Michael Kundi Austria
Jie Li China
Richard J. Jackson United States
Sean F. Altekruse United States
Cheng‐Chieh Lin Taiwan
Jérôme Vignat France
Hai‐Rim Shin South Korea
Wei Liu China
Guangwen Cao relative to ­Jun Li­ China ­Jun Li­'s profile →
Citations per field
00.5×1.5×
­Jun Li­ · 1×
Citations per year

Countries citing papers authored by Guangwen Cao

Since Specialization
Citations

This map shows the geographic impact of Guangwen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangwen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangwen Cao more than expected).

Fields of papers citing papers by Guangwen Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangwen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangwen Cao. The network helps show where Guangwen Cao may publish in the future.

Co-authorship network of co-authors of Guangwen Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Guangwen Cao. A scholar is included among the top collaborators of Guangwen Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangwen Cao. Guangwen Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 1
6 0
7 6
8 1
9 25
10 62
11 15
12 30
13 30
14 21
15 11
16 27
17 57
18 80
19 33
20 51

About Guangwen Cao

Guangwen Cao is a scholar working on Hepatology, Metals and Alloys and Cancer Research, having authored 425 papers that have together received 10.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (55 papers), Liver Disease Diagnosis and Treatment (38 papers) and Hepatitis C virus research (36 papers). The work is most often cited by research in Hepatology (1.8k citations), Cancer Research (1.3k citations) and Epidemiology (2.2k citations). Guangwen Cao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jianhua Yin, D L McGee, Y Liao, Richard S. Cooper, Xiaojie Tan, Yan Du, Hongwei Zhang, Jiaxin Xie, Hongyang Wang and Wenjun Chang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026